With the rising demand for manufacturing using highly potent active pharmaceutical ingredients (HPAPIs) being a huge trend in the industry, Chris talks about the flourishing biotech and oncology markets as well as the increase in ‘virtual’ pharmaceutical companies and their impact. He also discusses how the containment sector is expected to grow alongside this demand, as high potency manufacturers search for the best containment strategy. Ultimately, this means that more innovative solutions are coming to the market, particularly that of SMART monitoring technology.
You can read the full blog here
